Trial intelligence / Profile preview

Duloxetine for pain reduction after total knee arthroplasty

TCTR20200925002Phase 4Completed

Start
May 2020
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of duloxetine in postoperative pain, Chronic Pain after Total Knee Arthroplasty (CP-TKA), osteoarthritis (OA), sponsored by none. Started May 2020; status: completed.

02

Drugs

duloxetine
03

Conditions

postoperative painChronic Pain after Total Knee Arthroplasty (CP-TKA)osteoarthritis (OA)

Beyond the preview

Go deeper on TCTR20200925002.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20200925002.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call